PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31383551-0 2019 The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle glucose uptake. Glucose 160-167 delta like non-canonical Notch ligand 1 Homo sapiens 19-58 31383551-0 2019 The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle glucose uptake. Glucose 160-167 delta like non-canonical Notch ligand 1 Homo sapiens 60-64 21228248-2 2011 During oral glucose tolerance testing (OGTT), CFRD is defined by 2-h plasma glucose (PG2). Glucose 12-19 delta like non-canonical Notch ligand 1 Homo sapiens 85-88 31383551-9 2019 These Dlk1 effects seem independent of gluconeogenesis, but at least partly relies on increased in vivo glucose uptake in skeletal muscles by Dlk1 regulating the major glucose transporter Glut4 in vivo as well as in two independent cell lines. Glucose 104-111 delta like non-canonical Notch ligand 1 Homo sapiens 6-10 31383551-9 2019 These Dlk1 effects seem independent of gluconeogenesis, but at least partly relies on increased in vivo glucose uptake in skeletal muscles by Dlk1 regulating the major glucose transporter Glut4 in vivo as well as in two independent cell lines. Glucose 104-111 delta like non-canonical Notch ligand 1 Homo sapiens 142-146 26220259-4 2016 RESULTS: Baseline serum preadipocyte factor 1 levels showed a stepwise decrease across the glucose tolerance status groups at follow-up (normal glucose tolerance: 10.02 +- 3.02 ng/ml; prediabetes: 9.48 +- 3.35 ng/ml; diabetes: 8.66 +- 3.29 ng/ml; P for trend, 0.0151). Glucose 91-98 delta like non-canonical Notch ligand 1 Homo sapiens 24-45 26220259-4 2016 RESULTS: Baseline serum preadipocyte factor 1 levels showed a stepwise decrease across the glucose tolerance status groups at follow-up (normal glucose tolerance: 10.02 +- 3.02 ng/ml; prediabetes: 9.48 +- 3.35 ng/ml; diabetes: 8.66 +- 3.29 ng/ml; P for trend, 0.0151). Glucose 144-151 delta like non-canonical Notch ligand 1 Homo sapiens 24-45 26220259-5 2016 Individuals whose fasting plasma glucose level had increased or whose homeostasis model assessment of beta-cell function had decreased at follow-up showed significantly lower levels of preadipocyte factor 1 compared with their control group counterparts. Glucose 33-40 delta like non-canonical Notch ligand 1 Homo sapiens 185-206 25349437-6 2014 This increased DLK1 dosage caused improved glucose tolerance with no primary defect in adipose tissue expansion even under extreme metabolic stress. Glucose 43-50 delta like non-canonical Notch ligand 1 Homo sapiens 15-19 23979788-7 2013 In a combined population of all groups, circulating Pref-1 levels correlated positively with insulin, leptin and glucose levels and HOMA (homeostasis model assessment) index. Glucose 113-120 delta like non-canonical Notch ligand 1 Homo sapiens 52-58 21228248-2 2011 During oral glucose tolerance testing (OGTT), CFRD is defined by 2-h plasma glucose (PG2). Glucose 76-83 delta like non-canonical Notch ligand 1 Homo sapiens 85-88 20850471-5 2011 PG-2, a high M(w) fraction mainly composed of glucose presented significant cytotoxicity at the concentration of 200 and 100 mug/ml to human breast cancer cells. Glucose 46-53 delta like non-canonical Notch ligand 1 Homo sapiens 0-4 31886292-0 2019 Placental Delta-Like 1 Gene DNA Methylation Levels Are Related to Mothers" Blood Glucose Concentration. Glucose 81-88 delta like non-canonical Notch ligand 1 Homo sapiens 10-22 33640968-6 2021 Maternal DLK1 concentrations were positively associated with maternal pre-pregnancy BMI (p=3.5x10 6), and (after adjustment for maternal BMI) with both maternal fasting insulin resistance (HOMA IR: p=0.01) and measures of maternal insulin secretion in response to oral glucose (insulinogenic index: p=1.2x10 -3; insulin disposition index: p=0.049). Glucose 269-276 delta like non-canonical Notch ligand 1 Homo sapiens 9-13 31886292-1 2019 Purpose: We aim to identify the methylation status of delta-like 1 (DLK1) in the placenta and the correlation between DLK1 methylation and maternal serum glucose level and fetal birth weight. Glucose 154-161 delta like non-canonical Notch ligand 1 Homo sapiens 54-66 31886292-1 2019 Purpose: We aim to identify the methylation status of delta-like 1 (DLK1) in the placenta and the correlation between DLK1 methylation and maternal serum glucose level and fetal birth weight. Glucose 154-161 delta like non-canonical Notch ligand 1 Homo sapiens 118-122 31886292-4 2019 Furthermore, Pearson"s correlation was used to confirm the association of methylation alteration of DLK1 promoter and maternal 2 h OGTT glucose level and fetal birth weight. Glucose 136-143 delta like non-canonical Notch ligand 1 Homo sapiens 100-104 31886292-6 2019 Additionally, the methylation status of DLK1 gene in the maternal side of the placenta highly correlated with maternal 2 h OGTT glucose level (coefficient = 0.7968, P < 0.0001), while the methylation status in the fetal side of the placenta was closely related to fetal birth weight (coefficient = 0.6233, P < 0.0001). Glucose 128-135 delta like non-canonical Notch ligand 1 Homo sapiens 40-44